Protein researcher receives prestigious European award

Professor Matthias Mann has just received the prestigious Louis-Jeantet Prize for medicine for his outstanding results in areas such as cancer research. His work has significant therapeutic implications that could improve the diagnosis and treatment of for instance cancerous tumours.

Amarin receives special protocol assessment agreement

Amarin announced that it has reached agreement with the U.S. FDA under a Special Protocol Assessment for its planned Phase 3 clinical trial of AMR101 in patients with mixed dyslipidemia.

Prokarium receives grant to develop next generation vaccines

A consortium comprising vaccine developer Prokarium Ltd and the University of Birmingham’s Institute of Microbiology and Infection has received an award for 'advancing the industrial application of synthetic biology'.

Roche medicine Avastin receives EU approval

Roche has announced that the European Commission has approved Avastin (bevacizumab) in combination with standard chemotherapy as a treatment for women with first recurrence of platinum-sensitive ovarian cancer.





To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited